Description (Description)
Topiramate Tablet
Product Images NDC 80425-0208
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Topiramate (NDC 80425-0208). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Advanced Rx Pharmacy Of Tennessee, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Label 1 (Lable 1)
Fig 1 (Fig 1)
This is a graph showing the cumulative rates for time to first seizure in patients taking either Topiramate 50 mg/day or Topiramate 400 mg/day. The x-axis shows time in days and the y-axis represents the cumulative rates.*
Fig 2 (Fig 2)
The text describes the change observed in the average monthly migraine period rate during a double-blind phase study of a medication called TOPAMAX. Two dosages were used, 100 mg/day and 200 mg/day. The change observed was an increase of 56 in the migraine period rate compared to baseline. There is also statistical information indicating significant p-values for both dosages.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
